Industry Insights - The consumer discretionary sector shows a positive short-term trend, but the long-term outlook remains cautious. April data across sub-sectors improved compared to March, with the May Day holiday data maintaining or improving on this trend due to factors such as increased holiday periods, better weather, low base effects, government subsidies for appliances, and strong inbound tourism [2] - The outlook for May and Q2 is slightly positive, driven by structural rebounds in certain consumer sub-sectors, rational competition, favorable weather, increased subsidies from platforms like JD and Taobao, and sustained consumer power from inbound tourism [2] - The report suggests it is a good time to increase positions in leading companies within the sector [2] Company Analysis - BeiGene (百济神州) achieved its first quarterly GAAP profit, marking a significant milestone. In Q1 2025, product revenue reached $1.11 billion, a 48% year-on-year increase, with the drug Zebrutinib generating $792 million in sales, up 62% year-on-year [9] - The company reported a GAAP operating profit of $11 million and a net profit of $1 million in Q1 2025, with a significant improvement in non-GAAP operating profit compared to the previous year [9] - The gross margin for Q1 2025 rose to 85.1%, with a notable decrease in SG&A and R&D expense ratios, indicating ongoing cost control improvements [9] - The R&D pipeline for 2025 is expected to see key advancements, including ongoing clinical trials for various cancer treatments, with significant data releases anticipated [10] - The target price for BeiGene is maintained at $359.47, reflecting a positive outlook on revenue growth and R&D progress [10]

Macro Economic Overview - To counter the impact of tariffs, China has introduced a comprehensive monetary policy package aimed at boosting the stock and real estate markets. This policy will moderately ease liquidity and credit supply, encouraging positive market sentiment, although it cannot fully offset the economic impact of tariffs [2] - The report anticipates that the tariff impacts could reduce China's GDP and CPI growth rates by 1 percentage point and 0.2 percentage points, respectively. It is expected that GDP growth will slow from 5.4% in Q1 2025 to 4.5% in Q2, with a slight rebound to 4.7% in the second half of the year, resulting in an annual growth rate of 4.8% [5] Industry Insights - In the equipment manufacturing sector, global machinery manufacturers are assessing the impact of US tariffs, with most expecting effects to become apparent starting in Q3. Companies like Komatsu are predicted to face significant challenges due to these tariffs [5] - The Chinese insurance industry is set to see an acceleration of long-term investments as regulatory bodies announced a series of financial policies. This includes expanding the scope of long-term investment trials and adjusting risk factors for stock investments, potentially injecting over 150 billion yuan into the market [5] Stock Recommendations - Geely Automobile (175 HK) is rated as a "Buy" with a target price of 23.00, representing a 37% upside potential [6] - Xpeng Motors (XPEV US) is also rated as a "Buy" with a target price of 28.00, indicating a 46% upside [6] - Luckin Coffee (LKNCY US) is rated as a "Buy" with a target price of 40.61, suggesting a 24% upside [6] - Alibaba (BABA US) is rated as a "Buy" with a target price of 157.00, reflecting a 27% upside potential [6] - Tencent (700 HK) is rated as a "Buy" with a target price of 625.00, indicating a 28% upside [6]

2025 年 5 月 7 日 招银国际环球市场 | 市场策略 | 招财日报 每日投资策略 宏观及公司点评 全球市场观察 宏观经济 ◼ 美国经济 - 关税短期升成本作用超过降需求效应 美国 4 月服务业 PMI 超预期回升，商业活动延续扩张，需求小幅改善，关税 冲击尚未带来需求紧缩效应，反而通过刺激抢购囤货而带动零售、物流、仓 储和贸易活动；物价指数大幅反弹，与关税推升消费者通胀预期相一致。制 造业 PMI 收缩幅度扩大，生产指数大幅降至 2020 年 5 月以来新低；关税扰 动供应链导致交付时间变长，价格指数创近 3 年新高，企业库存下降。 招银国际研究部 数据公布后，美国 10 年国债利率上升 4bp 至 4.36%，市场对全年降息幅度预 期下降 3bp 至 76bp。短期内，关税推升成本作用超过降低需求效应，通胀反 弹风险大于失业上升风险，美联储在 5、6 月份可能保持政策利率不变。下半 年，随着需求收缩效应超过成本上升作用，就业市场可能明显放缓，通胀可 能见顶回落，美联储可能在 7 月或 9 月降息一次，11 月或 12 月再降一次。 （链接） 邮件：research@cmbi.com.hk | 环球主 ...

Group 1 - The beverage sector, particularly concentrated juice, has seen significant stock price increases following the May Day consumption surge, with Andeli Juice leading with a 52.38% rise [1][2] - Andeli Juice reported a revenue of 430 million RMB for Q1 2025, a year-on-year increase of 58.98%, and a net profit of 86.07 million RMB, up 61.31% year-on-year [2] - The increase in Andeli's performance is attributed to a rise in customer orders, leading to a substantial growth in concentrated juice sales [3] Group 2 - The global juice market is dominated by developed countries, but emerging markets like China, Russia, India, and Egypt are experiencing rising demand, providing growth opportunities for the industry [3] - The concentrated juice industry in China has undergone significant consolidation, with the market now primarily led by Andeli and Guotou Zhonglu, enhancing the bargaining power of leading companies [4] - The exit of smaller firms from the market has reduced supply, allowing top companies to strengthen their pricing power, indicating a shift from scale competition to value competition in the juice industry [4]

宏观、行业及公司点评 全球市场观察 宏观经济 美国经济 - 就业仍然稳健降低近期降息概率 2025 年 5 月 6 日 招银国际环球市场 | 市场策略 | 招财日报 每日投资策略 美国 4 月新增非农就业 17.7 万人，超出市场预期，显示美国就业市场仍然稳 健。时薪增速延续下降，已基本回到与 2%通胀目标相符的水平，预示核心服 务通胀将保持回落。每周工时与职位空缺数/失业人口比已低于疫情前水平， 显示劳动力市场供需平衡，预示目前的就业市场应对关税冲击的缓冲更小。 失业率保持在 4.2%，就业人数连续 2 月反弹。 数据公布后市场预期 6 月不降息的概率从 42%升至 69%，全年降息幅度从 91bp 降至 78bp。由于就业市场仍然稳健，关税可能推升近期通胀，我们预 计美联储 5 月和 6 月可能保持政策利率不变。由于市场对政策利率预期更加 招银国际研究部 邮件：research@cmbi.com.hk | 环球主要股市上日表现 | | | | | --- | --- | --- | --- | | | 收市价 | | 升跌（%） | | | | 单日 | 年内 | | 恒生指数 | 22,505 | 1. ...

港股饮料相关概念股午后集体冲高 智通财经5月6日电，港股饮料相关概念股午后集体冲高，安德利果汁大涨逾112%，茶百道涨超20%， 农夫山泉涨近8%，华润饮料、统一企业中国、蜜雪集团涨超3%。 ...

Group 1 - Non-alcoholic beverage stocks in Hong Kong experienced a significant rally in the afternoon session [1] - Andeli Juice (02218.HK) surged over 75%, indicating strong market interest [1] - Cha Bai Dao (02555.HK) rose more than 20%, reflecting positive investor sentiment [1] Group 2 - Nongfu Spring (09633.HK) increased nearly 8%, contributing to the overall sector growth [1] - China Resources Beverage (02460.HK), Gu Ming (01364.HK), and Mixue Group (02097.HK) all saw gains exceeding 3.5% [1]

Market Overview - Global markets showed mixed performance with the Hang Seng Index closing at 22,008, up 0.16% year-to-date increase of 29.10% [1] - The US markets continued to rebound, with the Dow Jones up 0.75% and the S&P 500 up 0.58%, reflecting a year-to-date increase of 7.53% and 16.58% respectively [1][3] Industry Insights - The equipment manufacturing sector reported Q1 2025 earnings, with SANY Heavy Industry exceeding expectations with a 56% year-on-year profit increase, driven by an 18% revenue growth [4] - The pharmaceutical company WuXi AppTec reported a strong Q1 2025, with revenue up 21% to 9.65 billion yuan and a non-IFRS net profit increase of 40% to 2.68 billion yuan [4][6] - Mindray Medical's revenue for 2024 was 36.7 billion yuan, a 5.1% increase, but faced challenges in the domestic market with a 12.1% decline in Q1 2025 revenue [7][8] Company Analysis - WuXi AppTec maintained its full-year guidance despite macro uncertainties, expecting a 10-15% revenue growth in its continuing operations for 2025 [4][6] - Mindray Medical's overseas revenue grew by 21.3% in 2024, accounting for 44.7% of total revenue, indicating strong international market performance [7] - Luckin Coffee reported a 41% year-on-year sales increase in Q1 2025, driven by strong same-store sales growth and rapid store expansion [11][12] Investment Ratings - SANY Heavy Industry is rated as a "Buy" with a focus on its excavator business cycle and overseas growth potential [4] - WuXi AppTec is also rated as a "Buy," with a target price of 77.22 yuan, reflecting confidence in its growth despite external challenges [6] - Mindray Medical is rated as a "Buy," with a target price of 249.19 yuan, anticipating recovery in domestic sales in the latter half of 2025 [8]

Market Overview - Global markets showed mixed performance with the Hang Seng Index closing at 21,972, down 0.04% for the day but up 28.89% year-to-date [1] - The A-share market experienced a slight decline, with the Shanghai Composite Index down 0.20% and the Shenzhen Composite Index down 0.93% [3] - Southbound capital recorded a net inflow of HKD 2.03 billion [3] Company Analysis BYD Electronics (285 HK) - The company reported flat earnings for Q1 2025, primarily due to weak demand for high-end smartphones and potential tariff impacts on Apple’s assembly business [4] - The gross profit margin improved by 0.4 percentage points to 6.3% quarter-on-quarter, but decreased by 0.6 percentage points year-on-year [4] - Management maintains a positive outlook for 2025, citing growth in Apple assembly, stable Android business, strong automotive demand, and growth in servers/robots [4] Wentech Technology (600745 CH) - The company’s revenue decreased by 19.4% year-on-year to RMB 13.1 billion, but net profit surged by 82.3% to RMB 261 million [5] - The gross margin recovered to 14.0%, indicating resilience in the semiconductor business [5] - The company is transitioning to focus on semiconductor business after divesting its ODM operations, which is expected to drive future growth [5] Li Ning (2331 HK) - Retail sales growth deteriorated in April 2025, with management noting a decline in offline channels due to adverse weather and a challenging macro environment [6][7] - Despite the challenges, the company maintains its full-year guidance, expecting stable sales growth and high single-digit net profit margins [6] - The company’s Q1 retail sales growth was in line with expectations, with online channels performing strongly [7] China Pacific Insurance (2601 HK) - The company reported a 39% year-on-year increase in new business value for Q1 2025, exceeding expectations [11][12] - However, the group’s net profit fell by 18.1% to RMB 9.63 billion, primarily due to declines in bond fair value and mismatches in yield curves [11] - The management expects operational profit to maintain low single-digit growth for the year, supported by business transformation [13] Zhejiang Dingli (603338 CH) - The company’s EBIT grew by only 2% year-on-year to RMB 440 million, with net profit increasing by 42% due to non-operating income [10] - The company faces challenges from unpredictable U.S. tariff policies, which may impact demand for its products in the U.S. market [10] - The target price remains at RMB 44, reflecting a cautious outlook on profitability [10] 康方生物 (9926 HK) - The company continues to show promise with its drug AK112, which has demonstrated efficacy in clinical trials against competitors [9][10] - The ongoing trials in overseas markets are expected to yield significant data, enhancing the drug's potential for approval and market entry [9][10] - The target price for 康方生物 is set at HKD 108.03, maintaining a buy rating based on the drug's promising results [10]

[Table_Summary] 公司公布 2025 一季报：2025 年第一季度，公司实现营业收入 8.17 亿元，同比下滑 12.76%； 实现归属于母公司净利润 0.73 亿元，同比增长 50.97%；实现扣非归母净利润 0.18 亿元，同 比下滑 62.33%。部分汽车客户减少预算，个别大项目投放进度较晚拖累收入，投资收益助推 利润增长，同时大幅改善现金流水平。公司布局体彩新业务，积极投资新赛道，打造全新增长 曲线，同时升级多模态 AI 产品，提升智慧营销能力。 分析师及联系人 [Table_Author] 高超 SAC：S0490516080001 SFC：BUX177 丨证券研究报告丨 公司研究丨点评报告丨三人行（605168.SH） [Table_Title] 部分汽车客户减少预算拖累业绩，培育多元增长 极 报告要点 请阅读最后评级说明和重要声明 %% %% %% %% research.95579.com 1 三人行（605168.SH） cjzqdt11111 [Table_Title 部分汽车客户减少 2] 预算拖累业绩，培育多元增 长极 [Table_Summary2] 事件描述 公司公布 ...